(Q40141195)

17 September 2017

Gene expression profiling of epidermal growth factor receptor/KRAS pathway activation in lung adenocarcinoma (English)

1 reference

17 September 2017

1 reference

1

Tatsuhiro Shibata

1 reference

17 September 2017

8

Setsuo Hirohashi

1 reference

17 September 2017

7

Michiie Sakamoto

1 reference

17 September 2017

5

Hisao Asamura

1 reference

17 September 2017

Satoko Hanada

2

1 reference

17 September 2017

Akiko Kokubu

series ordinal

3

1 reference

17 September 2017

Yoshihiro Matsuno

series ordinal

4

1 reference

17 September 2017

Tsutomu Ohta

series ordinal

6

1 reference

17 September 2017

23 April 2007

1 reference

17 September 2017

1 reference

17 September 2017

98

1 reference

17 September 2017

985-991

1 reference

17 September 2017

7

1 reference

Molecular classification and molecular genetics of human lung cancers

17 September 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00483.X

Genetic alterations of multiple tumor suppressors and oncogenes in the carcinogenesis and progression of lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00483.X

Tyrosine kinase inhibitors and the dawn of molecular cancer therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00483.X

Critical update and emerging trends in epidermal growth factor receptor targeting in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00483.X

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00483.X

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00483.X

EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00483.X

Somatic mutations of epidermal growth factor receptor signaling pathway in lung cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00483.X

Current management of advanced non-small cell lung cancer: targeted therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00483.X

Significance analysis of microarrays applied to the ionizing radiation response

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00483.X

Bcr interacts with components of the endosomal sorting complex required for transport-I and is required for epidermal growth factor receptor turnover.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00483.X

Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00483.X

Diversity of gene expression in adenocarcinoma of the lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00483.X

Expression profile-defined classification of lung adenocarcinoma shows close relationship with underlying major genetic changes and clinicopathologic behaviors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00483.X

CK20 expression, CDX2 expression, K-ras mutation, and goblet cell morphology in a subset of lung adenocarcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00483.X

EGFR mutation is specific for terminal respiratory unit type adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00483.X

Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00483.X

Clathrin- and non-clathrin-mediated endocytic regulation of cell signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00483.X

Distinctive activation patterns in constitutively active and gefitinib-sensitive EGFR mutants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2007.00483.X

10.1111/J.1349-7006.2007.00483.X

21 January 2018

Identifiers

DOI

1 reference

17 September 2017

1 reference